BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16310810)

  • 1. Molecular modeling of SWR-0342SA, a beta3-selective agonist, with beta1- and beta3-adrenoceptor.
    Ahmed M; Ishiguro M; Nagatomo T
    Life Sci; 2006 Mar; 78(17):2019-23. PubMed ID: 16310810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship studies of phenoxypropanolamine derivatives for beta 3-adrenergic activity.
    Ahmed M; Hanaoka Y; Nagatomo T
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):112P-113P. PubMed ID: 12491799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
    Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
    J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-obesity and anti-diabetic activities of a new beta3 adrenergic receptor agonist, (S)-(Z)-[4-[[1-[2-[(2-hydroxy-3-phenoxypropyl)]amino]ethyl]-1-propenyl] phenoxy] acetic acid ethanedioic acid (SWR-0342SA), in KK-Ay mice.
    Kiso T; Namikawa T; Tokunaga T; Sawada K; Kakita T; Shogaki T; Ohtsubo Y
    Biol Pharm Bull; 1999 Oct; 22(10):1073-8. PubMed ID: 10549858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptamine-based human beta3-adrenergic receptor agonists. Part 1: SAR studies of the 7-position of the indole ring.
    Mizuno K; Sawa M; Harada H; Tateishi H; Oue M; Tsujiuchi H; Furutani Y; Kato S
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5959-62. PubMed ID: 15546707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of pharmacological properties and selectivity of SWR-0315NA for beta3-adrenoceptors.
    Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Nagatomo T
    Biol Pharm Bull; 2004 May; 27(5):718-22. PubMed ID: 15133253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tertiary amine nitrogen atom of piperazine sulfonamides as a novel determinant of potent and selective beta3-adrenoceptor agonists.
    Perrone MG; Bleve L; Santandrea E; Vitale P; Niso M; Scilimati A
    ChemMedChem; 2009 Dec; 4(12):2080-97. PubMed ID: 19882697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog.
    Hicks A; McCafferty GP; Riedel E; Aiyar N; Pullen M; Evans C; Luce TD; Coatney RW; Rivera GC; Westfall TD; Hieble JP
    J Pharmacol Exp Ther; 2007 Oct; 323(1):202-9. PubMed ID: 17626794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel acetanilide derivatives as potent and selective beta3-adrenergic receptor agonists.
    Maruyama T; Onda K; Hayakawa M; Matsui T; Takasu T; Ohta M
    Eur J Med Chem; 2009 Jun; 44(6):2533-43. PubMed ID: 19232786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 1,7-cyclized indoles as a new class of potent and highly selective human beta3-adrenergic receptor agonists with high cell permeability.
    Mizuno K; Sawa M; Harada H; Taoka I; Yamashita H; Oue M; Tsujiuchi H; Arai Y; Suzuki S; Furutani Y; Kato S
    Bioorg Med Chem; 2005 Feb; 13(3):855-68. PubMed ID: 15653351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of novel phenoxypropanolamine derivatives containing acetanilides as potent and selective beta3-adrenergic receptor agonists.
    Maruyama T; Onda K; Hayakawa M; Seki N; Takahashi T; Moritomo H; Suzuki T; Matsui T; Takasu T; Nagase I; Ohta M
    Bioorg Med Chem; 2009 May; 17(9):3283-94. PubMed ID: 19362005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of beta1-, beta2-, and beta3-adrenoceptors in contractile hypersensitivity in a model of small bowel transplantation.
    Rickenbacher A; Seiler R; Honegger U; Shaw SG; Balsiger BM
    Surgery; 2008 Jan; 143(1):94-102. PubMed ID: 18154937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a novel, potent and selective human beta3-adrenergic receptor agonist.
    Nakajima Y; Hamashima H; Washizuka K; Tomishima Y; Ohtake H; Imamura E; Miura T; Kayakiri H; Kato M
    Bioorg Med Chem Lett; 2005 Jan; 15(2):251-4. PubMed ID: 15603933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
    Tanaka N; Tamai T; Mukaiyama H; Hirabayashi A; Muranaka H; Ishikawa T; Kobayashi J; Akahane S; Akahane M
    J Med Chem; 2003 Jan; 46(1):105-12. PubMed ID: 12502364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridines: novel selective beta3-adrenoceptor agonists.
    Zheng W; Nikulin VI; Konkar AA; Vansal SS; Shams G; Feller DR; Miller DD
    J Med Chem; 1999 Jun; 42(12):2287-94. PubMed ID: 10377236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism.
    Imbrogno S; Angelone T; Adamo C; Pulerà E; Tota B; Cerra MC
    J Exp Biol; 2006 Dec; 209(Pt 24):4966-73. PubMed ID: 17142685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human near-term myometrial beta 3-adrenoceptor but not the beta 2-adrenoceptor is resistant to desensitisation after sustained agonist stimulation.
    Rouget C; Breuiller-Fouché M; Mercier FJ; Leroy MJ; Loustalot C; Naline E; Frydman R; Croci T; Morcillo EJ; Advenier C; Bardou M
    Br J Pharmacol; 2004 Mar; 141(5):831-41. PubMed ID: 14769781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and selective, sulfamide-based human beta 3-adrenergic receptor agonists.
    Dow RL; Paight ES; Schneider SR; Hadcock JR; Hargrove DM; Martin KA; Maurer TS; Nardone NA; Tess DA; DaSilva-Jardine P
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3235-40. PubMed ID: 15149682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct interactions of human beta1- and beta2-adrenoceptors with isoproterenol, epinephrine, norepinephrine, and dopamine.
    Weitl N; Seifert R
    J Pharmacol Exp Ther; 2008 Dec; 327(3):760-9. PubMed ID: 18772317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.